Funding for drug discovery and therapeutic technology; LOI due April 10

To support drug discovery and therapeutic technology development efforts at OHSU, a new round of funding from the Biomedical Innovation Program has been announced.

The Biomedical Innovation Program supports and accelerates creative, trans-disciplinary drug discovery and therapeutic development research. Research involving — but not limited to — target validation, development of small molecules, antibodies, vaccines and biologics are candidates for this opportunity.

Letters of intent are due on April 10, 2018. See the 2018 RFA for details.

Program highlights:

  • Up to $60,000 in funding
  • Project management and hands-on support from Biomedical Innovation Program staff
  • Access to project-specific mentors and experts

The OHSU Oregon Clinical and Translational Research Institute and Technology Transfer and Business Development collaborate to offer the Biomedical Innovation Program. It is funded in part by the OHSU Foundation via the University Venture Development Fund.

Questions? Contact Jonathan Jubera at jubera@ohsu.edu, or visit the Oregon Clinical and Translational Research Institute Funding Opportunities page for more information.

Leave a Reply